Smith & Nephew plc ADR (SNN)

Precedente Chiudi:

$24.44

Aprire:

$25.09

Volume 24 ore:

1.06M

Capitalizzazione di mercato:

$10.83B

Reddito:

$5.55B

Utile/perdita netta:

$263.00M

Rapporto P/E:

49.56

EPS:

0.5

Flusso di cassa netto:

-

1 W Prestazione:

+1.35%

1M Prestazione:

+0.69%

6M Prestazione:

+2.91%

1 anno Prestazione:

-22.88%

Intervallo 1D:

$24.71

$25.16

Portata 52W:

$21.52

$32.70

Smith & Nephew plc ADR Stock (SNN) Company Profile

Nome

Smith & Nephew plc ADR

Settore

Healthcare (1213)

Industria

Medical Devices (160)

Telefono

44 20 7401 7646

Indirizzo

15 Adam Street, London

Dipendente

15,000

Cinguettio

@smithnephewplc

Prossima data di guadagno

Ultimi documenti SEC

SNN's Discussions on Twitter

Smith & Nephew plc ADR Stock (SNN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-11-28	Aggiornamento	Barclays	Underweight → Equal Weight
2023-11-03	Aggiornamento	JP Morgan	Neutral → Overweight
2023-10-31	Aggiornamento	HSBC Securities	Hold → Buy
2023-10-13	Iniziato	Stifel	Hold
2023-08-08	Aggiornamento	UBS	Sell → Neutral
2023-04-27	Downgrade	HSBC Securities	Buy → Hold
2023-04-11	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2022-12-12	Iniziato	Citigroup	Buy
2022-11-28	Downgrade	UBS	Neutral → Sell
2022-10-18	Iniziato	Morgan Stanley	Equal-Weight
2022-07-28	Downgrade	Canaccord Genuity	Buy → Hold
2022-03-16	Iniziato	RBC Capital Mkts	Outperform
2022-03-15	Iniziato	RBC Capital Mkts	Outperform
2022-03-04	Aggiornamento	Redburn	Sell → Neutral
2021-06-09	Aggiornamento	Credit Suisse	Neutral → Outperform
2020-12-18	Aggiornamento	Bernstein	Mkt Perform → Outperform
2020-12-01	Iniziato	Barclays	Overweight
2020-07-29	Aggiornamento	BofA Securities	Neutral → Buy
2020-06-04	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-04-14	Downgrade	Citigroup	Buy → Neutral
2019-11-21	Iniziato	Citigroup	Buy
2019-11-12	Iniziato	Bernstein	Outperform
2019-07-23	Aggiornamento	Berenberg	Hold → Buy
2019-02-08	Downgrade	Exane BNP Paribas	Outperform → Neutral
2019-01-02	Downgrade	JP Morgan	Overweight → Neutral
2018-12-10	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2018-11-01	Reiterato	Canaccord Genuity	Buy
2018-01-25	Aggiornamento	JP Morgan	Neutral → Overweight
2017-12-11	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2017-10-11	Iniziato	Canaccord Genuity	Buy
2017-02-27	Downgrade	Goldman	Buy → Neutral
2017-01-19	Iniziato	HSBC Securities	Hold
2016-12-08	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2016-10-06	Downgrade	Berenberg	Buy → Hold
2016-02-26	Iniziato	Cantor Fitzgerald	Hold

Mostra tutto

Smith & Nephew plc ADR Borsa (SNN) Ultime notizie

Smith+Nephew (SNN) Expands in Australia With New Alliance

Zacks Investment Research

Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia

GlobeNewswire Inc.

Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)

GlobeNewswire Inc.

Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds

GlobeNewswire Inc.

Fresenius Medical (FMS) to Unveil Training on Augmented Reality

Zacks Investment Research

Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner

GlobeNewswire Inc.

Smith & Nephew plc ADR Azioni (SNN) Dati Finanziari

Smith & Nephew plc ADR (SNN) Reddito 2024

Smith & Nephew plc ADR (SNN) Reddito netto 2024

Smith & Nephew plc ADR (SNN) Utile per azione 2024